O’Neal Comprehensive Cancer Center announces recipients of cancer-related research grants through O’Neal Invests

The O’Neal Comprehensive Cancer Center at UAB is pleased to announce its latest O’Neal Invests grant awards. O’Neal Invests funds UAB investigators initiating new cancer-related projects to do key preliminary work to enable competitive extramural applications. Applications for the eighth grant cycle were submitted in fall 2023.

The awardees receiving funding through O’Neal Invests include:

• Troy Randall, Ph.D.
  • Department of Medicine, Division of Clinical Immunology and Rheumatology
  • Pre-R01
  • Obesity, T Cell Metabolism, and Anti-Tumor Immunity in Adipose Tissue
• Satoru Osuka, M.D., Ph.D.
  • Department of Neurosurgery
  • Pre-R01
  • Targeting Radiation-Induced Invasion in Glioblastoma
• Erwin Van Meir, Ph.D.
  • Department of Neurosurgery
  • Pre-R01
  • BAI1 Regulation of IGF1R in Medulloblastoma
• Karin Hardiman, M.D., Ph.D.
  • Department of Surgery, Division of Gastrointestinal Surgery
  • Pre-R01
  • Creation of BACE1 Polymersomes to Overcome Resistance in Rectal Cancer
• Nicole Riddle, Ph.D.
  • Department of Biology
  • Catalyst
  • Exercise Impacts on Cancer Survival
• Anju Bansal, Ph.D., and Carissa Thomas, M.D., Ph.D.
  • Department of Medicine, Division of Infectious Diseases; Department of Otolaryngology
  • Catalyst
  • Single Cell Based Immune Profiling and Transcriptomics of Oropharyngeal Cancer

Catalyst grants are for $50,000 for one year. Pre-R01 grants are for $160,000 over two years.

There are two O’Neal Invests RFAs per year, in the spring and fall. Cancer Center membership is not a requirement to apply, but awardees must become members. The grants are peer-reviewed by a panel of UAB faculty.

In addition to these grants, three additional awards were funded through the generosity of the Breast Cancer Research Foundation. To read more about these grants, click here.

There are two O’Neal Invests RFAs per year, in the spring and fall. The new RFA for O’Neal Invests applications will be available February 1, 2024.